FORNARO, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 13.275
NA - Nord America 10.886
EU - Europa 8.300
SA - Sud America 1.638
Continente sconosciuto - Info sul continente non disponibili 611
AF - Africa 275
OC - Oceania 25
Totale 35.010
Nazione #
US - Stati Uniti d'America 10.456
SG - Singapore 5.798
IT - Italia 3.250
RU - Federazione Russa 3.050
VN - Vietnam 2.382
CN - Cina 2.360
BR - Brasile 1.330
HK - Hong Kong 1.124
FR - Francia 496
BD - Bangladesh 411
JP - Giappone 290
NL - Olanda 271
DE - Germania 254
CA - Canada 200
GB - Regno Unito 189
KR - Corea 157
IN - India 139
SE - Svezia 139
UA - Ucraina 122
MX - Messico 106
AR - Argentina 103
FI - Finlandia 103
ID - Indonesia 83
CI - Costa d'Avorio 77
AT - Austria 71
IE - Irlanda 71
IQ - Iraq 66
PH - Filippine 66
EC - Ecuador 62
TH - Thailandia 59
TR - Turchia 49
PL - Polonia 47
ES - Italia 45
TW - Taiwan 43
ZA - Sudafrica 43
PK - Pakistan 39
CO - Colombia 35
HU - Ungheria 34
JM - Giamaica 32
MA - Marocco 29
PY - Paraguay 27
CL - Cile 26
SA - Arabia Saudita 25
VE - Venezuela 25
JO - Giordania 20
EG - Egitto 19
UZ - Uzbekistan 19
AU - Australia 18
RO - Romania 17
LB - Libano 16
AE - Emirati Arabi Uniti 15
CH - Svizzera 15
IL - Israele 15
IR - Iran 14
BE - Belgio 13
DO - Repubblica Dominicana 13
MY - Malesia 12
TN - Tunisia 12
AL - Albania 11
CR - Costa Rica 11
ET - Etiopia 11
HR - Croazia 11
KE - Kenya 11
PE - Perù 11
TT - Trinidad e Tobago 11
AZ - Azerbaigian 10
HN - Honduras 10
UY - Uruguay 10
GR - Grecia 9
IS - Islanda 9
PT - Portogallo 9
BG - Bulgaria 8
DZ - Algeria 8
KZ - Kazakistan 8
NP - Nepal 8
SN - Senegal 8
BZ - Belize 7
GT - Guatemala 7
OM - Oman 7
SY - Repubblica araba siriana 7
GA - Gabon 6
LT - Lituania 6
NI - Nicaragua 6
RS - Serbia 6
EE - Estonia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
BO - Bolivia 4
BS - Bahamas 4
BW - Botswana 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
KG - Kirghizistan 4
LV - Lettonia 4
ME - Montenegro 4
NG - Nigeria 4
Totale 34.297
Città #
Singapore 2.825
San Jose 1.836
Hong Kong 1.081
Ashburn 835
Moscow 685
Hefei 590
Ho Chi Minh City 566
Beijing 463
Dong Ket 449
Santa Clara 435
Hanoi 412
The Dalles 365
Chandler 360
Millbury 342
Council Bluffs 335
Rome 332
Naples 326
Lauterbourg 306
Phoenix 271
Tokyo 258
Los Angeles 248
Dallas 232
Princeton 224
Des Moines 206
Nanjing 204
Milan 198
Buffalo 170
Redondo Beach 162
São Paulo 147
New York 146
Amsterdam 144
Seoul 113
Da Nang 97
Boston 91
Wilmington 78
Haiphong 77
Seattle 77
Frankfurt am Main 71
Orem 65
Shenyang 65
Turin 64
Chicago 58
Lawrence 58
Atlanta 57
Hebei 57
Nuremberg 56
Nanchang 54
Houston 53
Norwalk 53
Mexico City 52
Brooklyn 50
San Francisco 50
Toronto 48
Napoli 47
Bari 44
Jiaxing 44
Genoa 43
London 43
Rio de Janeiro 42
Ottawa 40
Catania 38
Montreal 38
Munich 38
Denver 34
Helsinki 34
Vienna 34
Tianjin 32
Baghdad 31
Biên Hòa 31
Casavatore 30
Falkenstein 28
Florence 28
Hải Dương 28
Palermo 28
Belo Horizonte 27
Boardman 27
Chennai 27
Jacksonville 26
Warsaw 26
Dublin 25
Stockholm 25
Lappeenranta 24
Manchester 24
Brasília 23
Johannesburg 23
Livorno 23
Redwood City 23
Bologna 22
Cagliari 22
Can Tho 22
Changsha 21
Bangkok 20
Curitiba 19
Kingston 19
Amman 18
Dhaka 18
Guangzhou 18
Guarulhos 17
Guayaquil 16
Padua 16
Totale 17.923
Nome #
Disturbo bipolare e malattie disreattive: una relazione complessa 1.095
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 592
Disturbo borderline e spettro bipolare: una ricerca epidemiologica 400
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 376
Comorbidità tra Disturbo da Deficit dell'Attenzione e Iperattività nell'adulto e Distubo Bipolare - prevalenza e caratteristiche cliniche in uno studio preliminare 357
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 318
Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes 258
Associate Editor 239
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 227
Valutazione elettroretinografica (ERG) in pazienti con depressione maggiore in trattamento con duloxetina: differenza tra “responders” e “non-responders” quale possibile indice di un pattern biologico differenziale. 197
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019 189
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 186
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 185
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 179
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 175
A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders 172
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 169
Impact of sex and complex PTSD comorbidity on pharmacological treatment response in bipolar disorder patients 168
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls 163
Atypical depression and emotion dysregulation: Clinical and psychopathological features 162
“Duloxetina e Bupropione in Medicina Generale” Aggiornamento ECM per Medici di Medicina Generale. Centro Ricerca G. De Lisio (Coordinatore Scientifico, Prof. G. Perugi), Pisa 15-12-2008. 161
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 160
“XLIV Congresso Nazionale della Società Italiana di Psichiatria (SIP) 2006”. Palacongressi d’Abruzzo, Montesilvano (Pescara) 15-20 ottobre 2006. (simposio dal titolo “L’identità dello Psichiatra: le opinioni degli specializzandi in Psichiatria italiani” – abstract book pp.247. 156
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 155
The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis 152
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 150
The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample 149
The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis 148
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 146
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? 143
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 142
Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective 140
Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis 138
VEGF plasma level variations in duloxetine-treated patients with major depression 138
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 136
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 136
Psychological perspective of medication adherence in transplantation 135
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 132
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 132
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects 131
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series 131
The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? 131
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 131
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 130
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 129
Homelessness and health-related outcomes: an umbrella review of observational studies and randomized controlled trials 129
Miglioramento clinico con bupropione della Sindrome delle Gambe Senza Riposo indotto dal trattamento con mirtazapna e duloxetina in un paziente affetto da Depressione Maggiore 129
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 129
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 129
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 128
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 128
Mental health during the 2022 Russo-Ukrainian War: A scoping review and unmet needs 127
Different measures of impulsivity in patients with anxiety disorders: a case control study 126
Studio dell'Asse Ipotalamo-Ipofisi-Surrene nei pazienti con Depressione Maggiore prima e dopo trattamento con Reboxetina 125
NGF serum levels variations in major depressed patients receiving duloxetine 125
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study 125
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 125
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 124
Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report 124
When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia 124
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 124
Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder 123
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates 123
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 123
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 123
BDNF plasma levels variations in major depressed patients receiving duloxetine 123
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 123
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 122
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? 122
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 122
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment 121
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 119
The impact of premenstrual dysphoric disorder among 92 bipolar patients 118
How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments 118
Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review 118
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 117
Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years 117
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 117
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 116
Medicine and psychiatry in Western culture: among Ancient Greek myths and modern prejudices 116
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds 116
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 115
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 114
Celiac disease and ADHD: mini-review and critique 114
Factor structure and reliability of the Arabic adaptation of the Hypomania Check List-32, second revision (HCL-32-R2) 113
Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report 113
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 110
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 110
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders 110
"Novel Psychopharmacology for Depressive Disorders" 110
Switch to mania after acute antidepressant treatment for bipolar depression: a systematic review and network meta-analysis of randomised controlled trials 110
Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials 109
Impulsività e disturbi d’ansia: il ruolo della ciclotimia 109
Defining clinical characteristics of emotion dysregulation in bipolar disorder: A systematic review and meta-analysis 108
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies 107
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 107
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 107
Is there a biosignature for lithium response in bipolar disorder? Evidence and implications 107
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management 106
Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity 105
Totale 15.841
Categoria #
all - tutte 107.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.314 0 0 33 57 30 94 51 68 93 103 147 638
2022/20231.389 307 98 48 59 114 141 36 90 196 145 102 53
2023/20241.613 71 171 145 116 80 60 139 183 73 105 290 180
2024/20258.474 524 744 66 107 277 350 845 653 895 770 2.474 769
2025/202617.042 1.758 1.479 1.761 1.263 2.430 588 1.724 1.312 2.406 1.025 666 630
2026/20272.766 704 1.295 767 0 0 0 0 0 0 0 0 0
Totale 35.010